Recombinant Human PDGF-BB GMP Protein: Usage Protocol

Recombinant Human PDGF-BB GMP Protein is a homodimeric, disulfide-linked growth factor manufactured under Good Manufacturing Practice (GMP) conditions for use in cell therapy research, stem cell expansion, and other applications requiring defined-quality reagents.

Product SKU

rp168345-GMP

R&D Reference

220-GMP

Protein Format

Recombinant, homodimeric, disulfide-linked

Grade

GMP (Good Manufacturing Practice)

Primary Application

Cell culture, stem cell expansion, cell therapy research

Recommended Carrier

Sterile PBS or BSA-containing buffer (see reconstitution section)

Materials Required

Before beginning the protocol, ensure the following materials are available:

• Recombinant Human PDGF-BB GMP Protein (SKU: rp168345-GMP)
• Sterile, ultrapure water or sterile phosphate-buffered saline (PBS, pH 7.4)
• Bovine serum albumin (BSA), carrier-protein grade, if required for dilution stability
• Sterile microcentrifuge tubes (1.5 mL or 0.5 mL)
• Calibrated micropipettes and sterile filter tips
• Appropriate cell culture medium and validated cell line or primary cells
• −20 °C or −80 °C freezer for long-term storage

Note: All materials coming into contact with the protein should be certified pyrogen-free to maintain GMP integrity of the reagent.

Reconstitution and Preparation

Follow these steps to reconstitute Recombinant Human PDGF-BB GMP Protein:

1. Equilibrate: Allow the vial to equilibrate to room temperature for 10–15 minutes before opening. Do not expose to direct heat.
2. Centrifuge: Briefly centrifuge the sealed vial (approximately 5 seconds at low speed) to collect lyophilized material at the bottom.
3. Add reconstitution buffer: Reconstitute with sterile PBS (pH 7.4). For working concentrations typically used in cell culture (e.g., 1–100 ng/mL), prepare a stock solution at 10–100 µg/mL. If prolonged storage of diluted aliquots is needed, supplement the buffer with 0.1% BSA (carrier-protein grade) to minimize adsorption to tube walls and improve stability.
4. Gentle mixing: Do not vortex. Gently swirl or pipette to mix until fully dissolved.
5. Aliquot: Divide the reconstituted stock into single-use aliquots to avoid repeated freeze-thaw cycles, which can degrade bioactivity.

Review flag: Exact recommended reconstitution volume and stock concentration are not specified in the supplied source material; consult the product datasheet (R&D reference 220-GMP) for confirmed values before use.

Storage and Stability

Proper storage is essential to maintain the bioactivity and GMP-grade quality of Recombinant Human PDGF-BB GMP Protein:

• Lyophilized (unopened): Store at −20 °C. Protect from moisture and light. Under recommended conditions, lyophilized cytokines are generally stable for up to 12 months; verify the expiry date on the certificate of analysis.
• Reconstituted stock (≥100 µg/mL): Store at −80 °C for longer-term preservation, or at −20 °C for up to 1 month. Avoid repeated freeze-thaw cycles; each cycle can reduce bioactivity.
• Diluted working solutions: Prepare fresh on the day of use when possible. If short-term storage is required, keep at 4 °C for no more than 24–48 hours.
• Carrier protein: Addition of 0.1% BSA to diluted solutions is recommended to reduce protein loss due to adsorption.

Note: Storage recommendations provided here reflect general best practices for lyophilized recombinant growth factors. Always consult the product-specific certificate of analysis and datasheet for confirmed stability data.

Cell Culture Application and Dosing

Recombinant Human PDGF-BB GMP Protein is commonly employed in research applications including mesenchymal stem cell (MSC) expansion, smooth muscle cell stimulation, and fibroblast proliferation assays. The following general guidance applies:

• Typical working concentration range: 1–100 ng/mL depending on cell type and assay. Dose–response titration is recommended for each new cell system to determine the optimal effective concentration (ED₅₀).
• Medium supplementation: Add the required volume of reconstituted PDGF-BB stock to pre-warmed, serum-free or low-serum medium immediately before use to avoid degradation.
• Replenishment: In long-term cultures, refresh PDGF-BB-supplemented medium every 48–72 hours, as cytokines are consumed and may degrade under culture conditions.
• Controls: Always include vehicle-only and no-growth-factor controls to distinguish specific PDGF-BB effects from basal medium effects.
• GMP context: When used in cell therapy manufacturing workflows, document lot numbers, reconstitution dates, and handling personnel in compliance with applicable regulatory requirements.

Review flag: ED50 values and specific application concentrations are not confirmed in the source material; verify with the product datasheet or peer-reviewed literature before committing to experimental concentrations.

Quality Control and Regulatory Considerations

As a GMP-grade reagent, Recombinant Human PDGF-BB GMP Protein (SKU: rp168345-GMP) is produced under quality systems designed to meet regulatory expectations for use in cell and gene therapy research and manufacturing:

• Certificate of Analysis (CoA): Each lot is accompanied by a CoA detailing purity, specific activity, endotoxin levels, and sterility testing results. Retain the CoA for traceability records.
• Endotoxin: GMP-grade cytokines are tested for endotoxin to meet limits appropriate for cell culture use. Check the lot-specific CoA for the confirmed endotoxin value.
• Purity: GMP-grade proteins are typically assessed by SDS-PAGE and/or HPLC. Consult the CoA for lot-specific purity data.
• Bioactivity: Bioactivity is confirmed by functional assay (e.g., proliferation assay on a PDGF-responsive cell line). Consult the CoA for the reported ED₅₀ value.
• Documentation: Maintain complete records of reagent receipt, storage conditions, reconstitution, and use in any GMP-compliant or GMP-adjacent workflow.

Review flag: Specific endotoxin limits, purity percentages, and bioactivity ED50 values are not provided in the source material; these must be obtained from the product CoA and datasheet (R&D reference 220-GMP).

Frequently asked questions

How should Recombinant Human PDGF-BB GMP Protein be reconstituted?

Reconstitute the lyophilized protein with sterile PBS (pH 7.4) to a stock concentration of 10–100 µg/mL. Gently swirl to mix; do not vortex. For improved stability in diluted working solutions, add 0.1% BSA. Always consult the product datasheet (R&D reference 220-GMP) for lot-specific reconstitution instructions.

What is the difference between GMP-grade and research-grade PDGF-BB?

GMP-grade PDGF-BB is manufactured under a Quality Management System with full batch documentation, enhanced endotoxin testing, sterility testing, and traceability — making it suitable for cell therapy manufacturing and regulatory-compliant workflows. Research-grade proteins are optimized for general laboratory use and may not carry the same level of documentation or quality system oversight.

How many freeze-thaw cycles can Recombinant Human PDGF-BB GMP Protein withstand?

To preserve maximum bioactivity, repeated freeze-thaw cycles should be minimized. It is best practice to aliquot the reconstituted stock into single-use volumes immediately after reconstitution and store at −80 °C. Each freeze-thaw cycle can reduce biological activity; specific tolerance data should be confirmed on the product CoA.

What cell types respond to PDGF-BB stimulation?

PDGF-BB signals through PDGF receptor beta (PDGFRβ) and the heterodimeric PDGFRα/β receptor, making it active on a broad range of mesenchymal cell types including fibroblasts, smooth muscle cells, pericytes, and mesenchymal stem cells. It plays roles in cell proliferation, migration, and survival signaling.

Is Recombinant Human PDGF-BB GMP Protein suitable for clinical use?

This product is intended for research and cell therapy manufacturing research purposes. Suitability for direct clinical or therapeutic use requires independent regulatory assessment and approval from the relevant health authority. Users must review applicable regulations before incorporating any reagent into a clinical workflow.

References

1. Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22(10):1276–1312. doi:10.1101/gad.1653708
2. Ross R, Glomset J, Kariya B, Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA. 1974;71(4):1207–1210. PMID:4526561
3. Aladdin Scientific. Recombinant Human PDGF-BB GMP Protein, SKU rp168345-GMP, Product Datasheet (R&D Reference 220-GMP). Aladdin Scientific; [date not specified in source].

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.